Related Experiment Video
Updated: Jul 9, 2026

Creating Radio-cephalic Arteriovenous Fistula in the Forearm with a Modified No-Touch Technique
Published on: April 1, 2022
Regional citrate anticoagulation for single-needle hemodialysis: a prospective clinical study
Jakob Gubensek1, Jadranka Buturovic-Ponikvar, Rafael Ponikvar
1Department of Nephrology, Center for Dialysis, University Medical Centre Ljubljana, Ljubljana, Slovenia. jakob.gubensek@kclj.si
Insights
Regional citrate anticoagulation is a safe and effective method for single-needle hemodialysis. This study demonstrates its efficacy in preventing clotting within the dialysis circuit, making it a viable option for patients requiring anticoagulation.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Biochemistry
Background:
- Hemodialysis requires effective anticoagulation to prevent circuit clotting.
- Regional citrate anticoagulation (RCA) offers an alternative to systemic anticoagulation, potentially reducing bleeding risks.
- Single-needle hemodialysis is an alternative access method that may benefit from optimized anticoagulation strategies.
Purpose of the Study:
- To prospectively evaluate the safety and efficacy of a regional citrate anticoagulation protocol specifically designed for single-needle hemodialysis.
- To assess the antithrombotic effectiveness of RCA within the hemodialysis circuit.
- To monitor for adverse events, particularly hypocalcemia, during RCA in this patient population.
Main Methods:
- A prospective study involving 15 chronic dialysis patients at risk of bleeding.
- Implementation of a specific RCA protocol using trisodium citrate, calcium-free dialysate, and calcium chloride infusion.
- Assessment of circuit anticoagulation via visual inspection and measurement of serum citrate levels post-dialysis.
Main Results:
- 94% of the 32 dialyses performed were uneventful, indicating high efficacy.
- A low incidence of asymptomatic severe hypocalcemia (6%) was observed.
- Excellent anticoagulation scores were achieved in the arterial bubble trap (4.8), dialyzer (4.6), and venous bubble trap (4.8).
- Mean serum citrate levels post-dialysis were 158 ± 60 micromol/l.
Conclusions:
- Regional citrate anticoagulation is a safe and efficient anticoagulation strategy for single-needle hemodialysis.
- The protocol effectively prevents clotting in the hemodialysis circuit.
- RCA is a promising anticoagulation method for hemodialysis patients, especially those with bleeding risks.
Aim:
Regional citrate anticoagulation protocol for single-needle hemodialysis was tested prospectively for safety and efficacy.
Methods:
15 chronic dialysis patients at risk of bleeding were included. 4% trisodium citrate (200 ml/h), calcium-free dialysate and 1 mol/l calcium chloride (7 ml/h) were used. After dialysis the antithrombotic effect in the circuit was assessed visually (grade 5, no clotting, to 1, total occlusion) and serum citrate was measured.
Results:
Of 32 dialyses performed, 94% were uneventful and in 2 cases (6%) there was severe (ionized calcium < or = 0.8 mmol/l) but asymptomatic hypocalcemia. Mean anticoagulation score after dialysis was 4.8 +/- 0.7 for the arterial bubble trap, 4.6 +/- 0.8 for the dialyzer and 4.8 +/- 0.7 for the venous bubble trap. Serum citrate after dialysis was 158 +/- 60 micromol/l.
Conclusion:
Regional citrate anticoagulation in single-needle dialysis is safe and efficient.
Related Concept Videos
Hemodialysis I: Introduction
Hemodialysis II: Procedure and Complications
Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
One of the advantages of...
Hemodialysis III: Nursing Management